Cleared Traditional

K123663 - LIQUIDCHEK CARDIAC MARKERS PLUS CONTROL LT (FDA 510(k) Clearance)

Also includes:
LEVEL 1C, LEVEL 2, LEVEL 3, TRILEVEL MINIPAK

Class I Chemistry device.

K123663 · Bio-Rad Laboratories · Chemistry device
Dec 2012
Decision
29d
Days
Class 1
Risk

K123663 is an FDA 510(k) clearance for the LIQUIDCHEK CARDIAC MARKERS PLUS CONTROL LT. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Bio-Rad Laboratories (Irvine, US). The FDA issued a Cleared decision on December 27, 2012 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

Submission Details

510(k) Number K123663 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 28, 2012
Decision Date December 27, 2012
Days to Decision 29 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Regulatory Context
Review time vs. panel average
205d faster than avg
Panel avg: 234d · This submission: 29d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.